Who we are
Board of directors
A full-service health care company. We invest in affordable and accessible solutions because everyone counts to us.
Stefanie Pieraets
Managing Director
Ann Tielemans
Marketing Director
Alain De Buf
Business Intelligence & Development Director
Dirk Schollaert
Supply Chain Director
Anne-Sophie Gernay
Pharmaceutical & Medical Affairs Director
Rémy Chibel
Sales Director
Jonas Verhoeven
Finance Director
Stefan De Ridder
Human Resources Director
Travailler chez Arega?
Are you ready for a new challenge in the pharmaceutical sector?
Stefanie Pieraets
Ann Tielemans
Alain De Buf
Dirk Schollaert
Anne-Sophie Gernay
Rémy Chibel
Jonas Verhoeven
Stefan De Ridder
Who we are
Supervisory Board
Arega werd in 2019 opgericht door Teun Grooters, Chris Olyslager en Mark Thomson en startte op basis van uitgebreide ervaring in klinische ontwikkeling en commercialisering in EU-markten haar activiteiten. Het aanbieden van betaalbare zorg voor iedereen was het belangrijkste speerpunt voor deze start met als slogan: ‘iedereen telt’.
Teun Grooters
Chairman, Founder
Mark Thomson
Founder
An Van den Acker
Secretary
Ideas for a healthy medicines market
1
Stop the race to the bottom
Imposed price reductions and unfair taxes lead to unhealthy price pressure that severely impacts generic medicines. This results in fewer generic medicines available on the market. The more suppliers there are, the smaller the risk of medicine shortages.
2
Stop the monopolies
Unhealthy price pressure caused by imposed price reductions, fines, and taxes disproportionately affects generic medicines. This results in fewer generic medicines on the market, and fewer suppliers inevitably lead to more shortages and... higher prices.
3
Encourage the prescription of generic medicines
Generic medicines create competition (i.e., a larger supply) and initiate a savings mechanism for the government and/or the patient. Quotas for prescribing by active ingredient, incentives for prescribing generic medicines, a more favorable reimbursement regime for these generic medicines... these are just a few of the measures the government can take to strengthen supply security.
4
Lower the threshold for prescribing by active ingredient
There is a simple measure the government can take to encourage a healthy market situation. For example, we propose prescription software where prescribing by active ingredient is the default option presented to the doctor. No more prescription software with an alphabetical ranking of brand-name medicines.
5
Value the pharmacist in their role
Encourage prescriptions by active ingredient to empower pharmacists in their role. Pharmacists are best positioned to make the right medication decisions for the specific patient. This results in less time wasted for doctors, pharmacists, and patients alike.
ESG
In a world in change, it has only become clearer in recent years that both privately and professionally everyone needs to make a contribution towards sustainability. In terms of the environment, society and governance. Within Arega, we consciously act towards this. The ESG criteria: Environment (environmental), Social (social), Governance (governance) are considered in all decisions taken by Arega.
We are always open to initiatives where we can make a positive impact. Do you have a suggestion? Feel free to contact us at info@arega.com
Environment
Electric vehicles are increasingly contributing to a better environment. So, Arega decided to convert its current company vehicle fleet from the traditional internal combustion engine to an eco-friendly electric motor to the maximum extent possible. Currently, 67% of the fleet is electrified. Ambition is to be at 90% by the end of 2025.
Social
Part of Arega’s mission is to invest in and find solutions to increase people’s comfort and well-being because everyone counts to us. That is why we regularly sponsor humanitarian and socially-oriented organisations. Because everyone counts to us.
Good governance
We ensure that everyone in the organisation follows appropriate and transparent decision-making processes and that the interests of all stakeholders are safeguarded and represented. Key concerns here are transparency, traceability and cross-departmental cooperation.
We continuously invest in training and development of our staff and a healthy company culture where responsibility is central.
Do you have a question, complaint or report of adverse reaction?
Contact us and we will make every effort to help you as soon as possible.
